State of Wyoming boosted its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 178.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,565 shares of the company’s stock after buying an additional 2,927 shares during the quarter. State of Wyoming’s holdings in DocuSign were worth $411,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of DOCU. Kestra Investment Management LLC acquired a new stake in DocuSign during the fourth quarter worth about $30,000. First Horizon Advisors Inc. boosted its position in DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock worth $36,000 after purchasing an additional 201 shares in the last quarter. Bessemer Group Inc. grew its stake in shares of DocuSign by 490.0% during the 4th quarter. Bessemer Group Inc. now owns 472 shares of the company’s stock worth $42,000 after purchasing an additional 392 shares during the period. Avion Wealth grew its stake in shares of DocuSign by 309.2% during the 4th quarter. Avion Wealth now owns 487 shares of the company’s stock worth $43,000 after purchasing an additional 368 shares during the period. Finally, Avior Wealth Management LLC increased its holdings in shares of DocuSign by 36.5% during the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after purchasing an additional 145 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.
DocuSign Price Performance
NASDAQ DOCU opened at $89.73 on Wednesday. The stock’s 50 day simple moving average is $81.71 and its 200-day simple moving average is $85.48. The company has a market cap of $18.17 billion, a PE ratio of 18.50, a price-to-earnings-growth ratio of 6.94 and a beta of 1.21. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on DOCU shares. JPMorgan Chase & Co. raised shares of DocuSign from an “underweight” rating to a “neutral” rating and increased their price target for the stock from $70.00 to $75.00 in a report on Monday, March 10th. Jefferies Financial Group lowered their target price on shares of DocuSign from $115.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday, March 31st. Morgan Stanley dropped their target price on DocuSign from $97.00 to $92.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 16th. JMP Securities reaffirmed a “market outperform” rating and issued a $124.00 price target on shares of DocuSign in a report on Thursday, April 17th. Finally, Hsbc Global Res upgraded DocuSign from a “moderate sell” rating to a “hold” rating in a research report on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $92.46.
Check Out Our Latest Research Report on DOCU
Insider Transactions at DocuSign
In other news, CFO Blake Jeffrey Grayson sold 8,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 15th. The stock was sold at an average price of $76.09, for a total value of $608,720.00. Following the completion of the sale, the chief financial officer now directly owns 86,156 shares in the company, valued at $6,555,610.04. This represents a 8.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $87.41, for a total value of $46,676.94. Following the transaction, the director now owns 8,270 shares in the company, valued at approximately $722,880.70. The trade was a 6.07% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 47,851 shares of company stock valued at $3,912,239. Corporate insiders own 1.01% of the company’s stock.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- The 3 Best Retail Stocks to Shop for in August
- Top 5 Stocks Hedge Funds Are Buying Right Now
- How to Use the MarketBeat Stock Screener
- Viking Holdings Posts Strong Q1, Eyes Growth Ahead
- Energy and Oil Stocks Explained
- 2 Reasons Netflix’s 40% Rally Is Far From Over
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.